A 57-year-old man with a history of polyuria and polydipsia was referred to the endocrine service in 1995 where a diagnosis of diabetes insipidus of both neurogenic and nephrogenic origin was made. Magnetic resonance imaging TOM G. SHEIDOW, DAVID A. NICOLLE, J. GODFREY HEATHCOTE (MRI) at the time of diagnosis showed minimal enlargement of the pituitary infundibulum; no orbital lesions were noted. His systemic condition remained stable for 11/z years at which time a routine chest radiograph showed cardiomegaly and prominent pulmonary vasculature. A moderate pericardial effusion was found and treated by the creation of a pericardial window on two separate occasions. Pathological examination of the pericardial tissue revealed fibrosis and active chronic inflammation.
In February 1997, bilateral periorbital skin changes prompted consultation with a dermatologist and the clinical diagnosis of xanthelasma was confirmed by biopsy. The ophthalmology service was also consulted because of symptoms of swelling around both eyes, soreness and photophobia. Examination revealed visual acuities of 20/20 in both eyes with full extraocular movements and mild lid lag. Diffuse xanthelasmata in the periorbital skin were noted and there was a bilateral superficial punctate keratopathy. The patient was treated for dry eyes and followed by the ophthalmology service at monthly intervals.
Two months later the patient was admitted to hospital with hyponatraemia and confusion secondary to the use of DDAVP (desmopressin). At that time slight, bilateral proptosis was noted with mild disc swelling but a computed tomography (CT) scan of the head was reported as normal. A subsequent deep vein thrombosis was accompanied by bilateral pleural effusions, suggestive of pulmonary thromboembolism. A CT scan of the abdomen at this time revealed a large area of retroperitoneal fibrosis.
In July 1997, radiographs of the femurs and tibias showed symmetrical osteosclerosis in the diaphyseal and metaphyseal regions. The combination of diabetes insipidus, pericardial effusions, retroperitoneal fibrosis and long bone changes raised the possibility of ECD. At the same time the neuro-ophthalmology service was consulted because of continuing difficulties with periorbital swelling, ocular irritation, tearing and near-vision. movements showed horizontal and vertical gaze restrictions with ptosis of the left eye and marked proptosis (26 and 27 mm) (Fig. 1a) . Conjunctival injection was present but the intraocular pressures were normal and fundus examination revealed only mild nasal blurring of the discs. Goldmann fields were normal. Urgent CT scans of the orbits showed bilateral proptosis with substantial intraconal soft tissue masses consistent with orbital pseudotumours (Fig. 2) .
The patient was started on prednisone 100 mg o.d. and appeared to remain stable from an ocular perspective. In September 1997, approximately 1 month later, the patient began a course of chemotherapy with three cycles of cladribine (2-CDA), each consisting of 11.5 mg daily for 5 days. Following the completion of the first cycle the patient noticed an increase in the periorbital swelling and decreasing vision (Fig. 1b) . Examination showed an increase in the degree of chemosis and continued restriction of ocular movement. Hertel measurements of 28 mm in the right eye and 30 mm in the left were obtained. Both optic discs remained normal. Radiation therapy was requested on an urgent basis but, before this could be given, the patient was admitted to the hospital 3 days later with a sudden onset of bilateral blindness, noted upon awakening. Visual acuity was no light perception in either eye with bilateral unreactive pupils. Initially neither disc showed evidence of swelling or pallor suggestive of a compressive effect of the pseudotumour. Intravenous solumedrol (1 g/day) and radiation therapy (2500 cGy) in 10 doses was given for 5 days without benefit. Repeat CT scans of the orbits showed no change in the retrobulbar masses. However, within 1 week, swelling and haemorrhage was noted within the optic disc bilaterally (Figs. 1c, d ).
Histopathological findings
The eyelid and pericardial biopsies were reviewed. In the dermis of the eyelid there was a patchy infiltrate of foamy macrophages of differing sizes. A few foamy cells were large with multiple nuclei and had the appearance of Touton giant cells (Fig. 3) . The well-circumscribed collections of foamy macrophages typical of xanthelasma were not seen. The pericardial tissue contained a mixed inflammatory cell infiltrate. Occasional histiocytes had foamy cytoplasm with more than one nucleus but classical Touton giant cells were not identified. retroperitoneal fibrosis and ureteral stenosis. Radiotherapy (4000 cGy) was given to the orbit and over the next 6 months the patients' ocular condition remained stable. However, the urological problems and hypertension related to the retroperitoneal fibrosis remained problematic and chemotherapy with azathioprine, initially 75 mg o.d. then increased to 75 mg b.i.d., was introduced. While on chemotherapy there was a gradual reduction in the restriction of the ocular movement. After 6 months of chemotherapy MRI showed no evidence of further progression in the size of the orbital pseudotumours. Azathioprine was continued and the prednisone gradually tapered. In September 1995, the patient was seen in follow-up and complained of left hip and back pain. Routine radiographs showed patchy medullary sclerosis and cortical thickening of the left proximal humerus, the distal femur bilaterally and the left proximal tibia. A bone scan indicated increased uptake of isotope in these areas and a tibial biopsy revealed thickening of the cortical bone and foamy macrophages infiltrating the marrow spaces. A clinical diagnosis of ECD was made. The patient remained stable on azathioprine and prednisone was tapered until December 1996, at which time diplopia returned with increased chemosis and (a) proptosis. Hertel measurements of 23 mm in the right eye and 25 mm in the left were recorded. Visual acuity had decreased to 20/25 in the right eye and 20/100 in the left, and repeat MRI showed some increase in the size of the orbital infiltrates. Radiation treatment (2000 cGy in 10 treatments) and prednisone 30 mg daily were re-initiated in January 1997. Again, following radiotherapy, the ocular condition stabilised and visual acuity returned to 20/40 in the left eye. Subsequently, the patient had progressive problems related to the increasing size of the retroperitoneal mass and its secondary effects on the urinary tract, with bilateral hydronephrosis requiring multiple stent procedures, nephrolithiasis, and finally renal failure on the right side. Echocardiography revealed diffuse global cardiac dysfunction but no evidence of pericardial disease. He gained significant amounts of weight secondary to the prednisone treatment and became diabetic.
In March 1999, following almost 2 years of stability in his ocular condition, the patient presented with a complaint of poor visual acuity of 10 days duration. The initial impression was of compression of the optic nerves and oral prednisone 50 mg o.d. was initiated. An initial (Fig. 1 e, f) . Thickening of the retina extended from this area through the fovea. A working diagnosis of multiple branch retinal vein occlusions, secondary to radiation retinopathy, was
made. An intravenous fluorescein angiogram revealed areas of non-perfusion inferiorly in both eyes and some neovascularisation ( Fig. 1 g, h) . 
Histopathology
The conjunctival, orbital and tibial biopsies were reviewed. Within the conjunctival epithelium, which was focally parakeratotic, there were scattered neutrophils.
The substantia propria contained a mixed inflammatory cell infiltrate and there was marked lymphangiectasia. The lymphoplasmacytic component was judged to be polyclonal on the basis of immunohistochemistry and neither foamy macrophages nor Touton giant cells were identified.
Review of the orbital biopsy from April 1994 revealed extensive replacement of orbital fat with fibrous tissue containing a diffuse mixed inflammatory infiltrate that included eosinophils and neutrophils (Fig. 5 ). There were numerous epithelioid histiocytes but no discrete granulomata. A high proportion of the histiocytes present had foamy cytoplasm and a few had more than one nucleus. However, classical Touton giant cells were not seen. Blood vessels with prominent endothelial cells and thickened walls were abundant. Lymphocytes were seen within the thickened vascular walls but there was no vasculitis. Histochemical stains for micro-organisms were negative and immunohistochemistry indicated a mixed infiltrate of T and B lymphocytes.
The core biopsy of the tibia revealed thickening of the bony trabeculae and diffuse replacement of the marrow spaces by foamy macrophages and a patchy lymphoplasmacytic infiltrate (Fig. 6) . A few of the foamy cells had multiple nuclei but Touton giant cells were not identified. Occasional multinucleated osteoclasts were seen in a paratrabecular location.
The orbital and tibial biopsies were considered consistent with the clinical diagnosis of ECD. The only specific signs for ECD are the radiological and histological findings. Skeletal radiographs show bilateral and symmetrical cortical osteosclerosis of the diaphyseal and metaphyseal regions of long bones. Although pathological examination of tissue is crucial for the diagnosis, it is rarely precise enough, as in our cases, to ensure the diagnosis. In fact, only 11 of the 59 reported cases 2 had full histological criteria for ECD, which include xanthomatous or xanthogranulomatous infiltrates with fibrosis, and no evidence of Langerhans cell histiocytosis (LCH). Commonly, the pathological report describes 'lipid-laden' macrophages or a xanthogranulomatous infiltration by nests of foamy histiocytes in fibrous tissue, as was seen in our cases. Sheets of xanthoma cells and occasionally Touton giant cells are features which distinguish ECD from sclerosing inflammatory pseudotumour. The absence of expression of S-100 protein and Birbeck granules may be of help to differentiate this condition from LCH; in the cases reported here, the histopathological findings were not consistent with a diagnosis of LCH.
Our cases, the 24th and 25th with orbital involvement, show the consultation of systemic findings that can be seen in ECD and highlight the variability in presentation. Case 1 presented with diabetes insipidus and cardiac involvement prior to the development of exophthalmos, whereas case 2 presented with exophthalmos. Case 1 is unique in that the patient suffered sudden, bilateral and complete loss of vision despite aggressive treatment with radiation, chemotherapy and steroids. The ophthalmological examination at the time of visual loss was not significantly different from an examination 3 days earlier, except for the dramatic change in acuity and the afferent pupillary defect. For this reason, we suspect that the underlying aetiology of the visual loss is a toxic injury to the optic nerve related to the chemotherapy with 2-CDA (cladribine). This may have predisposed the nerves to ischaemic injury when subjected to displacement by the retrobulbar masses.
Cladribine is a purine analogue used for treatment of a broad spectrum of indolent lymphoid malignancies. This agent, and others in its class, are known to be neurotoxic lO and a previous case of transient blindness occurring during therapy with cladribine has been reported Y Other forms of chemotherapy have been used in 8 other cases of ECD, with beneficial effects in only 4 cases. Our case 1 is the first reported use of 2-CDA in ECD.
Case 2 presented with bilateral orbital pseudotumours and required long-term azathioprine and two courses of radiotherapy for control of the orbital process. Radiation therapy was utilised in 6 of the patients previously reported without significant effect on the orbital lesions. In our case the response on both occasions to irradiation of the orbit was beneficial whereas only partial control of the retroperitoneal process was achieved by azathioprine. Radiotherapy would appear to have been more important than azathioprine in stabilising the orbital condition. Unfortunately, the development of radiation retinopathy with macular thickening has resulted in a substantial loss of vision in the patient's left eye and required both focal and panretinal photocoagulation in the right. No evidence exists in the literature for intraocular ECD and the appearance clinically and on intravenous fluorescein angiography supported the diagnosis of radiation-induced retinopathy. Furthermore, although retroperitoneal involvement is rarely symptomatic, our patient has had significant problems from his retroperitoneal mass and these continue to be a therapeutic challenge.
In summary, although most patients with ECD do not develop orbital disease, the combination of bilateral xanthelasmata and bilateral, diffuse orbital masses must suggest to the clinician the possibility of ECD, with its serious systemic problems. Implementation of steroid therapy in conjunction with systemic chemotherapy and orbital radiation therapy may have some influence on this otherwise progressive and sight-threatening disease.
